Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to the Shareholders of Däckskiftarna in the merger with Bythjul, a portfolio company of French investment group Mobivia Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on a €20m secondary offering of HRS shares Bryan, Garnier & Co acts as Sole Financial Advisor to Mint Media and its shareholders on the sale of Mint Media to Aleven Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ Nasdaq Stockholm SEK 210 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Indosuez Wealth Management on the acquisition of Wealth Dynamix Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders Bryan, Garnier & Co advises Carlyle on its investment in Groupe Lacour Bryan, Garnier & Co acts as Sole Bookrunner on Oncodesign Precision Medicine’s EUR 8 million Follow-on Offering & IPO on Euronext Growth Paris Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on the acquisition of the Machine & Perfusion division from Avionord S.r.l. Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Nicox’ Euronext Paris EUR 10 million Follow-on Offering & Warrants issuance Bryan, Garnier & Co acts as Sole Financial Advisor to the software company Groupe Positive (ex- Groupe Sarbacane) and its shareholders on its €110m fundraise led by EMZ Bryan, Garnier & Co acts as Sole Financial Advisor to Kaliti and its shareholders on the sale to Meanings
